Skip to content

Intraoral 30% Glucose Effect In Newborns

Baskent University Institutional Review Board

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02325583
Enrollment
19
Registered
2014-12-25
Start date
2014-01-31
Completion date
2014-10-31
Last updated
2014-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy, Hydrocephaly

Keywords

Intraoral 30% glucose, newborn, MRI

Brief summary

Newborn often sedated during MRI but sedation itself creates adverse events and management is more challenging in the MR environment. The investigators describe the investigators initial experience with oral 30% glucose administration through a pacifier during MRI for imaging of newborns. Using this technique, majority of newborns can complete MRI examination without the need for sedation and also offers the availability of administering sedatives to unsuccessful patients.

Detailed description

19 consecutive newborns over 10 months period were assessed retrospectively. 0.5-1 mL 30% glucose solution was administered orally and after suckling, the motionless and sleepiness of newborn was evaluated. If the target conditions was not achieved, 0.5-1 mL increments of glucose was added. After 2 consecutive oral glucose administration the newborns who did not keep motionless or sleep and had motion artefacts sedated with midazolam. The outcome measure was the success of the procedure which was determined by providing qualitative images appropriate for interpretation following 30% glucose administration. The routine blood glucose level measurement of the newborns after imaging procedures in the ICU was also performed for each patient.

Interventions

ORAL 30% GLUCOSE 0,5-2 ML

DRUGMidazolam

INTRAVENOUS 0.1 MG/KG MIDAZOLAM

Sponsors

Baskent University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Days to 30 Days
Healthy volunteers
No

Inclusion criteria

* Newborns admitted from newborn intensive care unit for MR imaging

Exclusion criteria

* Intubated newborns

Design outcomes

Primary

MeasureTime frame
Number of newborn provided qualitative images for MRI following oral glucose administration10 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026